KHK-IN-1

CAS No. 1303469-70-6

KHK-IN-1 ( Ketohexokinase inhibitor 8; KHK-IN-8 )

Catalog No. M26731 CAS No. 1303469-70-6

KHK-IN-1 is a reversible and ATP-competitive inhibitor of ketohexokinase (KHK) with IC50 of 12 nM. In the ATP-binding region of KHK, KHK-IN-1 interacts with Asp-27B.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 336 Get Quote
10MG 500 Get Quote
25MG 806 Get Quote
50MG 1098 Get Quote
100MG 1485 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    KHK-IN-1
  • Note
    Research use only, not for human use.
  • Brief Description
    KHK-IN-1 is a reversible and ATP-competitive inhibitor of ketohexokinase (KHK) with IC50 of 12 nM. In the ATP-binding region of KHK, KHK-IN-1 interacts with Asp-27B.
  • Description
    KHK-IN-1 is a reversible and ATP-competitive inhibitor of ketohexokinase (KHK) with IC50 of 12 nM. In the ATP-binding region of KHK, KHK-IN-1 interacts with Asp-27B.
  • Synonyms
    Ketohexokinase inhibitor 8; KHK-IN-8
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    GLP-1
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1303469-70-6
  • Formula Weight
    422.6
  • Molecular Formula
    C21H26N8S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CSc1ccccc1Nc1nc(nc2c(NCC3CC3)ncnc12)N1CCNCC1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Elahi D, et al. GLP-1 (9-36) amide, cleavage product of GLP-1 (7-36) amide, is a glucoregulatory peptide. Obesity (Silver Spring). 2008;16(7):1501-1509.
molnova catalog
related products
  • 5-Furfurylidene-2-Th...

    5-Furfurylidene-2-Thiobarbituric Acid is a tyrosyl-DNA phosphodiesterase inhibitor.

  • Cinepazide maleate

    A cerebral vasodilator that acts as a calcium blocker; protect neuronal cells against OGD injury by suppressing OGD-induced oxidative stress and preserving mitochondrial functions.

  • PKG drug G1

    PKG drug G1 targets C42 of PKG Iα. PKG drug G1 can couple to vasodilation and blood pressure lowering by a C42 PKG Iα-independent mechanism.